Robert Lutz

Chief Science Officer at Iksuda Therapeutics

With more than 25 years’ experience, Bob was previously Vice President of Translational Research and Development at ImmunoGen Inc., where he was responsible for all early-stage ADC development programs and gained further experience in directing the clinical pharmacology, biomarkers, pharmacology and toxicology departments. While at ImmunoGen, Bob was responsible for bringing eight of ImmunoGen’s candidate ADC products into development and was the research lead for Kadcyla


Org chart


Teams


Offices

This person is not in any offices


Iksuda Therapeutics

1 followers

Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics